BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 20, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Device rendering

FDA OKs Longeviti’s Clearfit implant for ultrasound

Jan. 26, 2021
By Meg Bryant
Longeviti Neuro Solutions LLC has received the U.S. FDA’s nod for use of its Clearfit cranial implant with postoperative ultrasound imaging. The expanded 510(k) clearance could help in reducing radiation exposure linked to other post-neurosurgical imaging modalities. Research has shown that current methods of post-neurosurgical imaging put patients at risk of radiation exposure, and that an estimated 29,000 future cancers could be linked to CT scan used in the U.S. each year. Comprised of polymethyl-methacrylate (PMMA), Clearfit is a neuro-reconstructive implant that surgeons use to reconstruct a patient’s cranium following brain surgery.
Read More
Cyclopharm-Technegas-pic-1-26

Australia’s Cyclopharm raises AU$30M ahead of U.S. launch of Technegas for pulmonary embolism

Jan. 26, 2021
By Tamra Sami
PERTH, Australia – Sydney-based Cyclopharm Ltd. raised AU$30 million (US$23.19 million) in a private placement that will enable the company to launch its Technegas combination product in the U.S.
Read More

Regulatory front for Jan. 26, 2021

Jan. 26, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Epigenomics out in Medicare NCD for CRC screening; TGA tweaks registration process for class I goods; Global initiative to take on Alzheimer’s; More on EMA cyberattack.
Read More

Regulatory actions for Jan. 26, 2021

Jan. 26, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aktiia, Alleviant, Inspired Spine, Longeviti, Spinal Elements.
Read More

Other news to note for Jan. 26, 2021

Jan. 26, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Asieris, Bc Platforms, Chronomics, Curadigm, Dante Labs, Digbi Health, Echosens, Electrocore, Emocha, Fuzionaire Radioisotope Technologies, Gastrologix, Genedx, Nanobiotix, Nihon Medi-Physics, Nova Mentis Life Science, Orasure, Opko Health, Perkinelmer, Photocure, Qualigen, Sanofi, Soliton, Soundbite, Yi Xin.
Read More

In the clinic for Jan. 26, 2021

Jan. 26, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Foldax.
Read More

Financings for Jan. 26, 2021

Jan. 26, 2021
Med-tech firms raising money in public or private financings, including: Personalis, TimelyMD, Titan Medical.
Read More

Appointments and advancements for Jan. 26, 2021

Jan. 26, 2021
New hires and promotions in the med-tech industry, including: Becton Dickinson.
Read More

BioWorld MedTech’s Oncology Extra for Jan. 26, 2021

Jan. 26, 2021
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Hypoxia a potential marker for recurrent glioblastoma; SCLC subtypes have specific vulnerabilities; Few-shot learning may speed up drug development; New research may move up breast cancer diagnosis.
Read More
U.S. flag and White House podium

Biden EOs keep on coming

Jan. 26, 2021
By Mari Serebrov
In signing an executive order (EO) on strengthening American manufacturing Jan. 25, President Joe Biden made it clear that the order is aimed at more than infrastructure. While Biden’s Build Back Better Recovery Plan calls for investing hundreds of billions of dollars in buying American products and materials to modernize the nation’s infrastructure and increase its competitiveness, “it also means replenishing our stockpiles to enhance our national security,” the president said.
Read More
Previous 1 2 … 1286 1287 1288 1289 1290 1291 1292 1293 1294 … 10248 10249 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 19, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Ebola virus particle

    Authorities work to quickly sequence Ebola species in latest outbreak

    BioWorld
    If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
  • Brain, illustrating pain/injury

    Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model

    BioWorld Science
    Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing